PDUFA Pilot Project: Proprietary Name Review - Concept Paper
Detailed guidance document from FDA and regulatory agencies.
Document Details
Concept Paper
October 7, 2008
April 27, 2020
c8f1f3f1-e618-4d0d-9264-921efbd1440f
Related Documents
S3A Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies
Concept PaperMarch 1, 1995Center for Drug Evaluation and Research
Q5C Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products
Concept PaperJuly 1, 1996Center for Drug Evaluation and Research
Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products: Guidance for Industry
Concept PaperNovember 1, 1995Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.